Compare BRID & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRID | SRTS |
|---|---|---|
| Founded | 1932 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.0M | 65.5M |
| IPO Year | 1995 | 2016 |
| Metric | BRID | SRTS |
|---|---|---|
| Price | $7.44 | $4.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.67 |
| AVG Volume (30 Days) | 3.0K | ★ 40.4K |
| Earning Date | 03-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $174,257,000.00 | $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.21 | N/A |
| 52 Week Low | $7.00 | $3.03 |
| 52 Week High | $8.73 | $5.92 |
| Indicator | BRID | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 50.10 |
| Support Level | $7.39 | $3.63 |
| Resistance Level | $8.06 | $4.80 |
| Average True Range (ATR) | 0.33 | 0.25 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 23.80 | 44.30 |
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The two business segments are: the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches, among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, mass merchandise, and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.